A simple blood test can tell doctors when it is safe to stop antibiotics in patients recovering from sepsis, a review led by ...
The North Wales community is rallying around Peter Atkinson and his family as he recovers from necrotizing fasciitis, which ...
Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for ...
Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data: Stockholm Friday, January 9, 2026, 11:00 Hrs [IST] Sobi, a global biopharma company, anno ...
Thailand: A comprehensive new meta-analysis suggests that fluctuations in blood glucose levels, rather than average glucose ...
Sobi (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant (emapalumab) for interferon-gamma (IFN?)-driven ...
BICARICU-2 aimed big but missed on mortality. Dr Aaron Holley explains what the sequel confirms about renal benefit, safety, ...
Exclusive: Possible revision of guidance for prosecutors in England and Wales comes amid safety concerns from courts ...
Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately ...
Narrowing the list of recommended childhood vaccinations isn't based on science, and misses what society actually needs to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback